⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

Official Title: Open-label Trial of Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

Study ID: NCT00928525

Interventions

Imatinib Mesylate

Study Description

Brief Summary: The purpose of this study is to determine whether Imatinib Mesylate is active in diseases - such as Desmoid Tumor and Chondrosarcoma - expressing the receptor for the platelet-derived growth factor (PDGF) both in its isoform alpha and beta

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Centro di Riferimento Oncologico - Unit of Medical Oncology, Aviano, Pordenone, Italy

I.R.C.C. - Unit of Medical Oncology, Candiolo, Torino, Italy

Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors, Bologna, , Italy

Policlinico S.Orsola Malpighi - Unit of Medical Oncology, Bologna, , Italy

Istituto Nazionale Tumori - Unit of Medical Oncology, Milano, , Italy

Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology I, Roma, , Italy

Ospedale Gradenigo - Unit of Medical Oncology, Torino, , Italy

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: